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Abstract
Background: Chronic musculoskeletal pain (CMP) affects daily life function and is the most prevalent disorder in
primary health care. The primary objective was to examine demographic factors and pain characteristics associated
with reduced health-related quality of life (HRQoL) among patients in primary care reporting CMP. Our secondary
objective was to compare HRQoL in patients with and without CMP.
Method: This cross-sectional study was conducted in Trondheim, Norway. Twenty randomly selected GPs, and their
listed patients aged 21–58 were invited to participate. Self-reported CMP data was collected using online
questionnaires. HRQoL was measured by the 15D questionnaire, total score of 0.9 was used as cut-off for clinical
reduced HRQoL.
Results: A total of 969 patients (650 females) were recruited from six GPs’ patient lists, mean age 45.6 (SD 10.1).
CMP was reported by 517 (53%). Factors significantly associated with reduced HRQoL were gender (OR 2.0, 95% CI
1.2, 3.4), disability pension (OR 26.6, 95% CI 3.1, 228.0), mood (OR 1.3, 95% CI 1.1, 1.6), relations with other people
(OR 0.8, 95% CI 0.6, 0.9), sleep (OR 1.2, 95% CI 1.0, 1.3) and enjoyment (OR 1.2, 95% CI 1.0). CMP patients had
significantly lower total HRQoL score compared to patients without CMP (Between group difference 0.08, 95% CI
0.07–0.09). Half of the CMP patients reported a HRQoL score < 0.9 compared to 14% in the no CMP group.
Conclusions: Being female, receiving disability pension, and several psychosocial factors were found highly
associated with reduced HRQoL in CMP patients, whereas pain characteristics were not. Patients with CMP reported
statistically and clinically significant lower HRQoL than patients without CMP. Due to low response rate the
conclusions must be handled with caution.
Trial registration: Clinicaltrials.gov (NCT02020772)
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Introduction
Chronic musculoskeletal pain (CMP) is characterized by
prolonged pain affecting muscles, joints or bones. CMP
may be single- or multi sited, and may be present in ab-
sence of any disease [1]. CMP is very common in the
general population and represents a major burden to
both the individual and the society [2]. Studies have
found CMP to be associated with reduced daily life func-
tion [3], disability, distress, self-perceived poor health
[4], and that CMP may lead to fatigue and insomnia [5–
11]. Further, CMP appears to be an independent pre-
dictor for high levels of sick leave [12, 13], and a leading
cause for seeking primary health care [14], substantially
contributing to inflating health care costs [14, 15]. CMP
may be defined according to the ICD-11 classification
system as “persistent or recurrent pain that arises as part
of a disease process directly affecting bone(s), joint(s),
muscle(s), or related soft tissue(s)” [16], persisting more
than three months [17]. The prevalence of CMP in Eur-
ope is about 20–36% [14, 18–20]. The risk of CMP in-
creases with age, and CMP is more prevalent among
women than men [14, 21–23]. Due to an aging popula-
tion, increased inactivity and obesity in the general
population, the prevalence and burden of CMP is ex-
pected to rise [10]. The Norwegian general population
study (the HUNT-study) [24] reported a 20% prevalence
of CMP in the general population, with rising numbers
during the four years follow-up. Interestingly, the ten-
dency of increasing prevalence was most evident in the
age group 20–29 years.
Chronic pain is found to be associated with reduced
health-related quality of life (HRQoL) in general [25,
26], and in different patient and diagnostic subgroups
[27–29]. A limited number of studies have assessed fac-
tors associated with reduced HRQoL in CMP patients.
Number of pain sites and pain intensity have been
highlighted as important factors affecting HRQoL, but
some studies have found stronger associations with
mental health factors, thus the causality of CMP remains
unclear [26, 30–32]. To improve management of CMP
patients in primary health care, and for clinicians to plan
and offer optimal treatment, further studies are needed.
The primary aim of this study was to examine demo-
graphic and pain characteristics associated with reduced
HRQoL among patients with CMP in primary health
care. Our secondary aim was to compare HRQoL among
patients with and without CMP.
Methods
Study design
This is a cross-sectional study based on data collected
from patients of general practitioners (GPs) in Trond-
heim municipality, Norway, during the period November
2013 to July 2015.
Subjects
Among 162 GPs in Trondheim, 20 GPs were randomly
identified by using a computer random number gener-
ator, developed and administrated at the Unit for Ap-
plied Clinical Research, Norwegian University of Science
and Technology (NTNU), Trondheim, Norway. The
randomization of GPs was stratified by gender, to pre-
vent gender influencing our patient selection and results.
The 20 randomly selected GPs were invited to partici-
pate in the study by postal mail and telephone. To bal-
ance urbane patient populations, we included two
additional GPs (male and female) from more rural areas.
The common age for pension in Norway is 67 years.
All patients registered in the GPs’ patient lists, aged 21
and 58 years were invited to participate in the study. The
age range 21 to 58 years was selected in order to ensure
that the included patients would be from a working
population throughout the three-year study period.
There were no medical exclusion criteria. All eligible pa-
tients received information about the study and an invi-
tation to participate by postal mail. Eligible patients
accepted the invitation by replying to the invitational let-
ter in writing, by phone, or by completing the web-based
questionnaire (CheckWare® online Survey system,
Norway). Informed consent was provided by logging into
the web-based questionnaire.
Measures
All data were collected by self-reported online question-
naires (CheckWare). The participants completed the
questionnaires within one month after consenting. An
automatic reminder was sent to non-responders after
three weeks.
Patients responding “yes” to the question “Have you
experienced pain and/or disabilities related to the mus-
cular or the skeletal system, with continuous duration of
at least 3 months during the last year?” were categorized
as experiencing CMP.
Health related quality of life
Measures developed for assessing HRQoL in patients
with chronic musculoskeletal pain include the Short
Form (SF)-36 Health Survey [33], the EuroQol five
dimensions questionnaire [34], the World Health
Organization QOL Questionnaire [35], and the 15D
questionnaire [36]. In the present study we chose to
assess HRQoL using the 15D questionnaire (www.15d-
instrument.net) [36] as the 15D is a 15-dimensional self-
reported, generic, and comprehensive questionnaire
measuring HRQoL in adults aged 16 years or older [36].
The Norwegian version of the 15D questionnaire has
previously been found valid and sensitive to measure
quality of life among patients with chronic pain [37, 38].
The 15 dimensions include mobility, vision, hearing,
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breathing, sleeping, eating, speech, excretion, usual activ-
ities, mental function, discomfort and symptoms, depres-
sion, distress, vitality and sexual activity. Each dimension
has five response alternatives; no problems, slight, con-
siderable, severe, or unbearable. The total 15D scoring
scale ranges from 0 representing “being dead” to 1 repre-
senting “perfect health-related quality of life” and no
problems in any dimension [36]. Population based pref-
erence weights were used to generate 15D sub scores
and the total 15D score (single index number). A change
of 0.015 or more in 15D HRQoL score is found to be
clinically relevant for self-perceived HRQoL [39]. A 15D
HRQoL total score below 0.9 represents a reduced
HRQoL of clinical relevance, and was used as the cut-off
value for reduced HRQoL in the present study [38, 40].
Pain related characteristics
Questions assessing pain related characteristics were de-
signed for this study based on questions from the “SF-36
Health Survey (SF-36®/SF-36v2®, Ware JE; Sherbourne
CD, 1990,1998)” [33, 41], the “Nordic musculoskeletal
questionnaire” (NMQ) [42], and the “Brief Pain Inven-
tory Long - Form (BPI)” [43]. Both the NMQ and the
BPI have been tested for validity and reliability, and
translated into Norwegian [44, 45]. Also the Norwegian
version of “SF-36 Health Survey” is psychometrically
tested and validated in a Norwegian population [46–48].
The patients who reported CMP were asked to indi-
cate pain sites, pain intensity and how musculoskeletal
pain influence general daily life function. Pain and dur-
ation of pain was assessed by the questions; 1.) “Do you
have current pain which has lasted for more than 6
months?” Yes/No. 2.) “How would you rate your current
pain?” 1. None, 2. Very mild, 3. Mild, 4. Moderate, 5. Se-
vere, 6. Very severe. Patients indicated pain location(s)
and number of pain sites on the NMQ digital pain map.
The response alternatives for pain sites were: head,
neck/shoulder, shoulder, upper back, chest, elbow, abdo-
men, lower back, hand, hip/thighs, knee, ankle/foot. For
the statistical analyses, pain sites were grouped into six
pain areas; head/neck/shoulder, chest/abdomen, elbow/
hand, upper back, lower back, hip/thigh/knee/ankle/foot.
Intensity of pain was assessed by patients rating the in-
tensity of their current perceived pain on an 11-point
numerical rating scale ranging from “0” (No pain), to
“10” (Worst pain imaginable). For the statistical analyses
current pain intensity was categorized as no to little pain
(0–2), as low to moderate pain (3–5), as severe pain (6–
8), and very severe pain (9–10). How pain influenced
various daily life functions during the last 24 hours was
evaluated by participants rating functions such as gen-
eral activity, mood, walking ability, normal work, rela-
tions with other people, sleep, and enjoyment on a 11-
point numerical rating scale from no influence (0) to
large influence (10). A mean score was calculated for
each variable. Current self-reported health was reported
as either excellent, very good, good, fair or poor, and
self-assessed economic status was reported as either
good, fair, poor [49, 50].
Ethics
The Regional Committee for Medical and Health Re-
search Ethics in Central Norway (2012/1232) approved
the study and study procedures followed the Helsinki
Declaration. The participants signed digital informed
consent prior to participation. The participants who
attended the study were part of a prize draw for a gift
card worth 500 NOK.
Statistics
Participant characteristics and demographic variables are
presented as mean and standard deviation (SD), or
number (n) and percentage (%), as appropriate. When
comparing participants with and without CMP the inde-
pendent samples t-test was used for continuous variables
(age), the Chi-square test was used for dichotomous
variables, and the Mann-Whitney U-test for ordinal
variables.
Due to a skewed distribution of 15D scores, HRQoL
was dichotomized using a threshold of 0.9 in order to
analyze factors associated with HRQoL using univariable
and multivariable logistic regression analyses. An odds
ratio (OR) above 1 represents an increased risk of
reporting reduced HRQoL (total 15D score below 0.9).
Statistically significant variables in the univariable ana-
lyses were included in multivariable analysis. P-values
less than 0.05 were considered statistically significant.
The statistical analyses were conducted using IBM SPSS
Statistics version 25 and R version 2.13.1.
Results
Six GPs (three male and three female) agreed to partici-
pate. Among the eligible patients aged 21–58 in the GPs’
lists, 972 (23.3%) agreed to participate (Fig. 1).
Subject characteristics and demographic variables
Just over half of the included patients (517/969) reported
CMP. CMP patients were significantly older, had lower
education and more worked part-time compared to pa-
tients without CMP (Table 1). Approximately one in
three CMP patients reported their health to be “not so
good”, compared to 8% in patients without CMP.
Current sick leave due to CMP was reported by 13%,
and almost half (46.3%) had been on sick leave for more
than three months (Table 1).
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HRQoL among patients with and without CMP
The total 15D HRQoL score and the 15D HRQoL di-
mension scores (15 categories) for the two groups are
presented in Fig. 2. The patients with CMP reported sig-
nificantly lower mean total HRQoL score compared to
the patients without CMP (between group difference
0.08, 95% CI 0.07, 0.09) (Table 1). In the present study, a
15D total score < 0.9 represents a clinical reduction in
HRQoL. Half of the patients with CMP reported a total
score below 0.9 compared to 14% in the no CMP group.
The 15D HRQoL dimension sub scores were signifi-
cantly lower among patients with CMP compared to
participants without CMP in most dimensions, except in
the dimensions “Eating” (p = 0.13) and “Vision” (p =
0.06). The highest between-groups difference in the 15D
sub scores were found in the dimensions “Discomfort/
Symptoms” (CMP 0.79, SD 0.23, no CMP 0.87, SD 0.17,
p ˂0.001) and “Sleeping” (CMP 0.75, SD 0.22, no CMP
0.88, SD 0.19, p ˂0.001) (Fig. 2).
Demographic factors associated with HRQoL among
patients with CMP
The univariable logistic regression analyses showed that
being female, receiving disability pension, and having no
occupational activity were factors significantly associated
with reduced HRQoL (a total score below 0.9). Patients
who had completed higher education and/or in full time
employment had a significantly lower risk of reporting
reductions in HRQoL. In the multivariable regression
analyses, being female and receiving disability pension
were the only demographic factors that remained signifi-
cantly associated with reduced HRQoL (total score
below 0.9), although the confidence interval for receiving
disability pension was very wide (Table 2).
Pain characteristics among patients with CMP and their
associations with HRQoL
The majority of CMP patients reported three pain sites
or more, and the most common pain site was the lower
back. Most patients graded their current pain intensity
as “low” to “moderate”, and among daily life activities,
sleep and general daily activity were most affected by
pain. In the univariable logistic regression analyses,
almost all the pain-related variables were significantly as-
sociated with reduced HRQoL (total score below 0.9).
Factors that remained significantly associated with
reduced HRQoL in the multivariable analyses were
everyday life functions affected by pain such as mood,
relations to other people, sleep and enjoyment (Table 3).
Discussion
In this cross-sectional observational study among 969
patients in primary health care practice, 53% reported
CMP. Among the CMP patients, nearly half experienced
lower back pain, most had low to moderate pain inten-
sity, and more than half reported three or more pain
sites. CMP patients had significantly lower total HRQoL
score compared to patients without CMP, and “Discom-
fort/Symptoms” and “Sleeping” were the HRQoL dimen-
sions most influenced by CMP. Half of the group of
CMP patients reported a HRQoL score representing a
clinically impaired quality of life. In the multivariable
Fig. 1 Flow-chart of study participants (n = 969)
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Table 1 Demographic characteristics of primary health care patients grouped according to presence of chronic musculoskeletal
pain (CMP) (n = 969)
Patient characteristics Chronic Muskuloskeletal Pain (n = 517) No chronic Muskoloskeletal Pain (n = 452) P-value
n (%) n (%)
Age (years) mean (SD) 45.6 (10.1) 42.6 (10.2) ˂ 0.01*
21–30 years 57 (11.3) 66 (17.8)
31–40 years 88 (17.5) 101 (23.3)
41–50 years 156 (31.0) 134 (30.9)
51 years and older 202 (40.2) 121 (27.9)
Missing 14 (2.7) 17 (3.8)
Gender 0.36**
Female 354 (68.5) 296 (65.7)
Male 163 (31.5) 156 (34.3)
Marital status 0.13***
Married/cohabitant 405 (78.6) 348 (77.5)
Single 74 (14.4) 77 (17.1)
Divorced/Separated/Widowed 36 (7.0) 24 (5.2)
Missing 2 (0.4) 3 (0.7)
Education ˂ 0.01***
Primary/secondary school 175 (34.0) 106 (23.5)
University ˂ 4 years 141 (27.4) 137 (30.4)
University ˃ 4 years 172 (33.4) 190 (42.1)
Student/other 27 (5.2) 18 (4.0)
Missing 2 (0.4) 1 (0.2)
Occupational activitya
None 28 (5.4) 15 (3.3) 0.12**
Full time work 358 (69.2) 348 (77.0) ˂ 0.01**
Part time work 80 (15.5) 57 (12.6) 0.23**
Under education 33 (6.4) 31 (6.9) 0.80**
Disability pension 35 (6.8) 3 (0.7) ˂ 0.001**
Receiving benefit payments 369 (71.4) 309 (68.4) 0.33**
Self-assessed economic status 0.02***
Good 273 (53.2) 277 (61.6)
Fair 205 (40.0) 153 (34.0)
Poor 35 (6.8) 20 (4.4)
Missing 4 (0.8) 2 (0.4)
Self-assessed health ˂ 0.001***
Very good 59 (11.4) 180 (40.0)
Good 257 (49.8) 231 (51.3)
Not so good 174 (33.7) 37 (8.2)
Poor 26 (5.0) 2 (0.4)
Missing 1 (0.2) 2 (0.4)
HRQoL total 15D score mean (SD) 0.88 (0.10) 0.95 (0.06) ˂ 0.001*
HRQoL total 15D score < 0.9 254 (50.2) 63 (14.1) ˂ 0.001**
Missing 9 (1.7) 6 (1.3)
Current sick leave due to CMP 69 (13.3) -
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analyses, only gender and receiving disability pension
remained significantly associated with reduced HRQoL
among the demographic variables. Among the pain-
related variables, the multivariable analyses showed that
psychosocial factors such as impaired mood, sleep and
enjoyment were significantly associated with increased
risk of reporting reduced HRQoL, whereas the risk of
impaired HRQoL was lower for patients who had rela-
tions with other people. Interestingly, current pain and
pain sites were not associated with HRQoL in the multi-
variable analyses.
Strengths and limitations
Our study is unique as it included an unselected group
of patients in primary health care. Considering that,
most CMP patients suffer from multisite pain, and most
studies on CMP pain include single-site pain patients,
the findings of our study may be highly relevant for
daily clinical practice in primary health care and pro-
vide important information about the general burden
of CMP. Further, the current study included a high
number of participants and comprehensive informa-
tion regarding pain characteristics and daily life func-
tion, which in turn gives us a valuable basis for
exploring factors associated with HRQoL in this
population. Assessing multiple aspects involved in the
complex mechanism of CMP is vital in order to de-
velop effective strategies to prevent and limit negative
consequences of CMP at both individual and societal
level. The 15-D questionnaire is a valid and reliable
tool for measuring pain among primary care patients
as it uses both a profile system to describe 15 dimen-
sions important for quality of life, and an index sys-
tem using population-based preferences.
Table 1 Demographic characteristics of primary health care patients grouped according to presence of chronic musculoskeletal
pain (CMP) (n = 969) (Continued)
Patient characteristics Chronic Muskuloskeletal Pain (n = 517) No chronic Muskoloskeletal Pain (n = 452) P-value
n (%) n (%)
Missing 5 (0.9) -
Duration of current sick leave
0–3 months 37 (53.6) -
3–6 months 15 (21.7) -
˃ 6 months 17 (24.6) -
Missing 5 (0.9) -
Numbers are presents as n (%) unless otherwise stated
Abbreviation: HRQoL Health Related Quality of Life
*Independent Samples T-Test; **Chi-squared test; ***Mann-Whitney U-test
aMultiple response alternatives was allowed for occupational activity
Fig. 2 HRQoL measured by 15D HRQoL questionnaire among patients with and without CMP, presented by mean sub-score for all 15
dimensions and the mean total 15D HRQoL score
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There are some limitations to this study. Our study
design was cross-sectional, thus we cannot imply causal-
ity or directional relationship between the different fac-
tors and HRQoL. Further, the patients themselves
reported whether they fulfilled the criteria for CMP, thus
the CMP categorization was mostly based on the pa-
tients’ subjective evaluation and understanding of CMP.
Only one in four patients invited to the study (23%),
agreed to participate and the response rate from both
GPs and patients was relatively low. However, consider-
ing that approximately one in four patient in Norwegian
general practice presents with musculoskeletal disorders
[14], and that 53% (n = 517) of all invited list patients of
the GP’s met the eligibility criteria for CMP, it is likely
that we recruited a high proportion of patients who ex-
perienced or had experienced long-lasting musculoskel-
etal pain during the past 12 months. However, for
background variables such as occupational activity, sick
leave, prevalence of musculoskeletal disorders, disability
pension/benefits the our study population is similar to
the general Norwegian population in the report about
work and health by the Norwegian Institute of Public
Health [51]. In addition, the study population is the rela-
tively large, thus we consider our study population to be
representative for patients with CMP in primary health
care. As the main focus in the present study was to ex-
plore demographic factors and pain characteristics, we
did not control for confounding factors known to affect
HRQoL such as anxiety, depression and physical activity.
This might have introduced bias to our findings and our
results must therefore be interpreted with caution.
Comparison with other studies
Approximately half of the study population reported
CMP. This is similar to a previous Danish study among
390 patients in general practice [52]. Sorensen and
colleagues (2019) also found that 47% of GP patients
reported musculoskeletal pain, with a duration range of
9–85 weeks [52]. In concurrence with several previous
Table 2 Demographic factors and associations with reduced health-related quality of life (15D HRQoL total score < 0.9) among
patients with chronic musculoskeletal pain: results from logistic regression analyses (n = 517)
Demographic characteristics Univariable analyses Multivariable analyses
OR CI OR CI
Age (years) (n = 503)
21–30 years 0.9 0.5, 1.6
31–40 years 0.6 0.4, 1.0
41–50 years 1.0
51 years and older 1.2 0.8, 1.9
Gender (n = 517)
Female 1.70 1.16, 2.49 2.0 1.2, 3.4
Male 1.0 1.0
Marital status (n = 515)
Married/cohabitant 1.0
Single 0.8 0.5, 1.3
Divorced/Separated/widowed 1.7 0.8, 3.4
Education (n = 515)
Primary/secondary school 1.0
University < 4 years 0.6 0.4, 1.0
University > 4 years 0.6 0.4, 0.9
Student/other 0.7 0.3, 1.5
Occupational activitya (n = 517)
None 3.9 1.6, 9.8 1.9 0.5, 7.0
Full time work 0.4 0.2, 0.5 0.9 0.5, 1.6
Part time work 1.3 0.8, 2.1
Student 0.8 0.4, 1.7
Receiving disability pension 38.8 5.3, 286 26.6 3.1, 228
Bold indicates statistically significance
Abbreviations: OR Odds ratio, CI Confidence interval
aMultiple response alternatives was allowed for occupational activity, analysed as individual variables
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studies, we found a higher prevalence of CMP among
women [3, 14, 21–23, 53].
Similar to previous findings, HRQoL was significantly
lower among CMP patients compared to patients with-
out CMP [26, 32, 54–56]. We estimated a mean differ-
ence in total HRQoL score between groups of 0.08. A
difference of 0.015 or more between groups has previ-
ously been found to be clinically relevant [39]. Among
the 15 dimensions included in the total 15D HRQoL
score, the CMP patients in our study reported the lowest
scores in the two dimensions “Sleeping” and “Discom-
fort/Symptoms”. The scores in the dimensions “Usual
activities” and “Vitality” were also clearly lower com-
pared to patients without CMP.
The primary aim of our study was to examine demo-
graphic factors and pain characteristics associated with
HRQoL among CMP patients in primary health care
practice. A limited number of studies have assessed im-
portant factors for HRQoL in this particular population.
However, similar to our findings, a Norwegian cross-
sectional study including a general population of chronic
pain patients aged 19–81 (n = 1893) [26], found no asso-
ciation between self-reported pain and number of
chronic illnesses, or global quality of health. Wahl and
colleagues (2009) found that stress related symptoms, fa-
tigue and poor self-perceived health was highly associ-
ated with lower HRQoL among CMP patients [26].
Jones and colleagues [57] addressed factors associated
Table 3 Pain characteristics among primary health care patients with chronic musculoskeletal pain (CMP) and associations with
health-related quality of life: results from logistic regression analyses (n = 517)
Pain-related characteristics CMP patients Univariable analyses Multivariable analyses
n (%) OR 95% CI OR 95% CI
Number of pain siteg mean (SD) 3.5 (2.3)
0–2 208 (40.2) 1.0 1.0
3–5 214 (41.4) 2.5 1.7, 3.8 1.6 0.9, 2.7
6–8 73 (14.1) 9.0 4.7, 17.3 2.0 0.7, 5.7
9–12 21 (4.1) 12.1 3.4, 42.9 1.5 0.2, 10.9
Pain sitesa mean (%)
Head/neck/shoulder 87 (16.8) 4.4 2.6, 7.6 1.7 0.8, 3.7
Chest/abdomen 176 (34.0) 4.5 1.3, 15.9 2.9 0.6, 13.8
Elbow/hand 16 (3.1) 1.4 0.9, 2.0
Upper back 134 (25.9) 2.0 1.4, 3.1 0.8 0.5, 1.5
Lower back 235 (45.5) 2.1 1.5, 3.0 1.3 0.8, 2.1
Hip/thigh/Knee/ankle/foot 39 (7.5) 3.1 1.5, 6.6 1.2 0.4, 4.4
Current pain intensityb mean (SD)
0–2 No to little pain 238 (46.0) 1.0 1.0
3–5 Low to moderate 195 (37.7) 3.9 2.6, 5.8 0.9 0.6, 1.0
6–8 Severe 73 (14.1) 8.5 4.5, 16.1 1.1 0.6, 13.4
9–10 Very severe to worst pain ever experienced 3 (0.6) 4.6 0.4, 51.1 0.7 0.4, 36.3
Pain more than 6 monthsc 420 (81.2) 3.9 2.3, 6.4 1.3 0.7, 2.6
Pain influence on everyday life mean (SD)
General activityd 3.0 (2.6) 1.5 1.4, 1.6 1.1 0.9, 1.3
Moodd 2.5 (2.6) 1.6 1.5, 1.8 1.3 1.1, 1.6
Walking abilityd 1.6 (2.4) 1.4 1.2, 1.5 1.1 0.9, 1.2
Normal working abillity b 2.7 (2.8) 1.5 1.3, 1.6 1.0 0.9, 1.2
Relations with other peopleb 1.7 (2.4) 1.6 1.4, 1.8 0.8 0.6, 0.9
Sleepe 2.9 (2.9) 1.5 1.4, 1.6 1.2 1.0, 1.3
Enjoymente 2.4 (2.6) 1.7 1.5, 1.8 1.2 1.0, 1.5
Numbers are n (%) unless otherwise stated; Bold indicates significant association between CP and pain related characteristics
CMP Chronic musculoskeletal pain, SD Standard deviation
Missing: an = 516; bn = 515; cn = 514; dn = 513; en = 512; fn = 509
gMultiple response alternatives were allowed for occupational activity, analysed as individual variables
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with HRQoL among 47 patients with chronic pain and
opioid abuse. In concurrence with our findings, they re-
ported pain intensity to be of importance for HRQoL in
the univariable analyses. However, the multivariable ana-
lyses showed that pain itself was less important, while
pain management, pain interference on daily life, and
symptoms of depression were significantly associated
with HRQoL. Malmberg-Ceder and colleagues (2016)
found that psychosocial and lifestyle factors had a stron-
ger association with work engagement than pain alone
among employees with CMP [58]. Moreover, in a study
among patients with chronic low back pain, high symp-
tomatic burden, rather than perceived pain was found to
be a strong predictor for reduced HRQoL [59]. In a
previous study exploring predictors of quality of life
among 1208 chronic pain patients, Lamè and co-
workers (2004) showed that pain catastrophizing had
the strongest association with quality of life in this
group [60]. In the present CMP study population,
multisite pain was more prevalent than single site
pain, and the lower back was the most commonly re-
ported pain site. These findings correspond to previ-
ous large studies of chronic pain [14, 61]. A higher
number of pain sites and low back pain have been
shown to reduce physical and work capacity [62],
which in turn are associated with reduced daily life
function and HRQoL [3, 60, 63]. In contrast, we
found no statistically significant association between
number or type of pain sites and HRQoL in our
multivariate analyses, although several psychological
variables related to daily life functions showed a
strong association with HRQoL. Studies have shown
multisite chronic pain to be associated with a major
somatic symptom burden [64], which in turn may
affect the patients’ physical and mental state of
health, and the ability to cope with, and recover from,
chronic pain [3, 65]. Studies exploring factors affect-
ing quality of life among CMP patients indicate very
complex and multifactorial associations, where daily
life function and mental wellbeing seem to be of
major importance for quality of life [64].
Among the demographic characteristics, we found that
female CMP patients had lower HRQoL compared to
male CMP patients. This is in concurrence with the study
by Wahl et al. (2009), who found that female chronic pain
patients had lower global quality of life than male chronic
pain patients [26]. Possible reasons for this gender differ-
ence warrants further studies. Interestingly, receiving dis-
ability pension was associated with reduced HRQoL. This
may be explained by assuming that these patients having
endured long duration of pain, disabilities and functional
disorders affecting their daily life. However, these results
should be cautiously interpreted due to small sample and
a large confidence interval.
Interpretation
Even though multisite pain is common among patients
with CMP, most research on CMP and HRQoL have fo-
cused on populations with single-site specific musculo-
skeletal pain disorders. Therefore, our study on
characteristics and associations with HRQoL in an un-
specified group of CMP patients in primary health care
practice may provide important knowledge about the
state of health and potential variables associated with
quality of life. Discrepancies between reported study
findings may be due to differences in pain duration and
prevalence of co-existing musculoskeletal disorders. In
the present study, few participants reported current sick
leave due to CMP, which may indicate that our study
population consisted of many patients with a relatively
low symptom burden or that they were able to manage
work despite pain. Inclusion criteria for CMP in this
study was self-reported pain and/or disabilities related to
the musculoskeletal system for 3 months or longer dur-
ing the last year, indicating the patients were suffering
or had suffered a recent chronic pain condition. Enhan-
cing the knowledge base on CMP is of major importance
in order to develop more precisely targeted prevention
and treatment strategies in the primary health care sys-
tem for this group of patients. Our findings may be use-
ful for primary health care personnel, especially GPs and
physiotherapists in clinical practice, by increasing their
awareness of pain rarely being a single important factor
for quality of life in this population.
Generalisability
All participants included in our study were informed of
the main focus; musculoskeletal pain. We included a
high number of patients in primary health care with pre-
vious and present symptoms related to the musculoskel-
etal system, also among patients in the group without
CMP. Our population consisted of patients receiving on-
going treatment in primary health care, and patients on
the GPs’ patient lists currently receiving no active treat-
ment. There were more females in the CMP group, and
participants were slightly older, had lower education and
more worked part-time compared to the group without
CMP. In addition, receiving disability pension was more
frequent, and self-assessed economic status and health
status tended to be lower among CMP patients. These
characteristics of CMP patients, in addition to multisite
pain and low back pain being the most prevalent pain
site, are in concurrence with findings in previous studies,
and indicate that our study population may be represen-
tative of CMP patients in general [3, 56, 60, 66]. Beside
age between 21 and 58 years, there were no further in-
clusion criteria in our study, and we targeted all CMP
patients in primary health care practice. Thus, our find-
ings may be generalizable to the general population of
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CMP patients with typical sociodemographic character-
istics and general CMP burden.
Conclusions
Just over half of the recruited primary health care pa-
tients reported CMP. Being female, receiving disability
pension and psychosocial factors such as mood, sleep,
enjoyment and relation to other people were identified
as factors strongly associated with reduced HRQoL in
CMP patients. Pain intensity, pain sites and type of pain
sites were not significantly associated with reduced
HRQoL. CMP patients reported significantly lower
HRQoL than patients without CMP, and the total score
indicate reduced quality of life of clinical importance for
everyday living among the majority of CMP patients. Be-
cause of the relatively low response rate in our study,
the conclusions must be handled with caution.In pri-
mary health care practice, it may be important to estab-
lish strategies aiming to improve psychological well-
being among CMP patients and to be aware of how pos-
sible gender differences may affect quality of life in CMP
patients.
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